Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1876 | 2448 | 51.8 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
21 | 4 | UROLOGY & NEPHROLOGY//UROL//JOURNAL OF UROLOGY | 229838 |
272 | 3 | PROSTATE CANCER//PROSTATIC NEOPLASMS//UROL | 43768 |
534 | 2 | ANDROGEN RECEPTOR//PROSTATE CANCER//CASTRATION RESISTANT PROSTATE CANCER | 14838 |
1876 | 1 | ANDROGEN RECEPTOR//GEORGE WHIPPLE CANC//CASTRATION RESISTANT PROSTATE CANCER | 2448 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANDROGEN RECEPTOR | authKW | 1818223 | 30% | 20% | 731 |
2 | GEORGE WHIPPLE CANC | address | 261063 | 3% | 30% | 70 |
3 | CASTRATION RESISTANT PROSTATE CANCER | authKW | 219796 | 4% | 18% | 100 |
4 | PROSTATE CANCER | authKW | 189936 | 26% | 2% | 638 |
5 | CASTRATION RESISTANCE | authKW | 160151 | 1% | 38% | 34 |
6 | S REPROD BIOL | address | 148589 | 1% | 35% | 34 |
7 | AR V7 | authKW | 135798 | 1% | 78% | 14 |
8 | ANTIANDROGEN | authKW | 101210 | 3% | 11% | 72 |
9 | ANDROGEN INDEPENDENCE | authKW | 99873 | 1% | 30% | 27 |
10 | ENZALUTAMIDE | authKW | 94313 | 2% | 19% | 39 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 11556 | 36% | 0% | 886 |
2 | Endocrinology & Metabolism | 11016 | 26% | 0% | 646 |
3 | Urology & Nephrology | 5551 | 14% | 0% | 353 |
4 | Cell Biology | 2364 | 17% | 0% | 426 |
5 | Biochemistry & Molecular Biology | 2282 | 28% | 0% | 690 |
6 | Andrology | 916 | 1% | 0% | 31 |
7 | Chemistry, Medicinal | 209 | 4% | 0% | 86 |
8 | Genetics & Heredity | 61 | 4% | 0% | 88 |
9 | Pathology | 52 | 2% | 0% | 50 |
10 | Medicine, Research & Experimental | 36 | 3% | 0% | 66 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GEORGE WHIPPLE CANC | 261063 | 3% | 30% | 70 |
2 | S REPROD BIOL | 148589 | 1% | 35% | 34 |
3 | ANDROGEN SIGNALLING | 69279 | 0% | 56% | 10 |
4 | VANCOUVER PROSTATE | 62289 | 2% | 13% | 40 |
5 | UROL | 60767 | 30% | 1% | 733 |
6 | DAME ROMA MITCHELL CANC S | 55405 | 1% | 19% | 23 |
7 | CANC BASIC SCI | 32063 | 0% | 43% | 6 |
8 | SEX HORMONE | 26553 | 1% | 12% | 18 |
9 | EQUIPE PHYSIOL COMPAREE ENDOCRINOL MOL | 24944 | 0% | 100% | 2 |
10 | MED TECHNOL CANC GENET | 24944 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROSTATE | 75597 | 7% | 4% | 166 |
2 | MOLECULAR ENDOCRINOLOGY | 27223 | 5% | 2% | 111 |
3 | ENDOCRINE-RELATED CANCER | 15210 | 2% | 3% | 45 |
4 | HORMONES & CANCER | 10459 | 0% | 8% | 11 |
5 | CANCER RESEARCH | 7504 | 6% | 0% | 155 |
6 | MOLECULAR AND CELLULAR ENDOCRINOLOGY | 7175 | 3% | 1% | 71 |
7 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 5576 | 3% | 1% | 64 |
8 | CLINICAL CANCER RESEARCH | 3454 | 3% | 0% | 65 |
9 | ONCOTARGET | 3102 | 2% | 0% | 56 |
10 | MOLECULAR CANCER THERAPEUTICS | 2709 | 1% | 1% | 30 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANDROGEN RECEPTOR | 1818223 | 30% | 20% | 731 | Search ANDROGEN+RECEPTOR | Search ANDROGEN+RECEPTOR |
2 | CASTRATION RESISTANT PROSTATE CANCER | 219796 | 4% | 18% | 100 | Search CASTRATION+RESISTANT+PROSTATE+CANCER | Search CASTRATION+RESISTANT+PROSTATE+CANCER |
3 | PROSTATE CANCER | 189936 | 26% | 2% | 638 | Search PROSTATE+CANCER | Search PROSTATE+CANCER |
4 | CASTRATION RESISTANCE | 160151 | 1% | 38% | 34 | Search CASTRATION+RESISTANCE | Search CASTRATION+RESISTANCE |
5 | AR V7 | 135798 | 1% | 78% | 14 | Search AR+V7 | Search AR+V7 |
6 | ANTIANDROGEN | 101210 | 3% | 11% | 72 | Search ANTIANDROGEN | Search ANTIANDROGEN |
7 | ANDROGEN INDEPENDENCE | 99873 | 1% | 30% | 27 | Search ANDROGEN+INDEPENDENCE | Search ANDROGEN+INDEPENDENCE |
8 | ENZALUTAMIDE | 94313 | 2% | 19% | 39 | Search ENZALUTAMIDE | Search ENZALUTAMIDE |
9 | ANDROGEN RECEPTOR AR | 92736 | 1% | 28% | 27 | Search ANDROGEN+RECEPTOR+AR | Search ANDROGEN+RECEPTOR+AR |
10 | ARN 509 | 84180 | 0% | 75% | 9 | Search ARN+509 | Search ARN+509 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | YUAN, X , CAI, C , CHEN, S , CHEN, S , YU, Z , BALK, SP , (2014) ANDROGEN RECEPTOR FUNCTIONS IN CASTRATION-RESISTANT PROSTATE CANCER AND MECHANISMS OF RESISTANCE TO NEW AGENTS TARGETING THE ANDROGEN AXIS.ONCOGENE. VOL. 33. ISSUE 22. P. 2815 -2825 | 103 | 65% | 64 |
2 | TAN, MHE , LI, J , XU, HE , MELCHER, K , YONG, EL , (2015) ANDROGEN RECEPTOR: STRUCTURE, ROLE IN PROSTATE CANCER AND DRUG DISCOVERY.ACTA PHARMACOLOGICA SINICA. VOL. 36. ISSUE 1. P. 3 -23 | 106 | 55% | 33 |
3 | COUTINHO, I , DAY, TK , TILLEY, WD , SELTH, LA , (2016) ANDROGEN RECEPTOR SIGNALING IN CASTRATION-RESISTANT PROSTATE CANCER: A LESSON IN PERSISTENCE.ENDOCRINE-RELATED CANCER. VOL. 23. ISSUE 12. P. T179 -T197 | 114 | 68% | 0 |
4 | LALLOUS, N , DALAL, K , CHERKASOV, A , RENNIE, PS , (2013) TARGETING ALTERNATIVE SITES ON THE ANDROGEN RECEPTOR TO TREAT CASTRATION-RESISTANT PROSTATE CANCER.INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. VOL. 14. ISSUE 6. P. 12496-12519 | 95 | 75% | 11 |
5 | WATSON, PA , ARORA, VK , SAWYERS, CL , (2015) EMERGING MECHANISMS OF RESISTANCE TO ANDROGEN RECEPTOR INHIBITORS IN PROSTATE CANCER.NATURE REVIEWS CANCER. VOL. 15. ISSUE 12. P. 701 -711 | 75 | 55% | 55 |
6 | CAO, SB , ZHAN, Y , DONG, Y , (2016) EMERGING DATA ON ANDROGEN RECEPTOR SPLICE VARIANTS IN PROSTATE CANCER.ENDOCRINE-RELATED CANCER. VOL. 23. ISSUE 12. P. T199 -T210 | 85 | 74% | 1 |
7 | BERGERAT, JP , CERALINE, J , (2009) PLEIOTROPIC FUNCTIONAL PROPERTIES OF ANDROGEN RECEPTOR MUTANTS IN PROSTATE CANCER.HUMAN MUTATION. VOL. 30. ISSUE 2. P. 145 -157 | 99 | 74% | 34 |
8 | GREEN, SM , MOSTAGHEL, EA , NELSON, PS , (2012) ANDROGEN ACTION AND METABOLISM IN PROSTATE CANCER.MOLECULAR AND CELLULAR ENDOCRINOLOGY. VOL. 360. ISSUE 1-2. P. 3-13 | 84 | 71% | 52 |
9 | CHMELAR, R , BUCHANAN, G , NEED, EF , TILLEY, W , GREENBERG, NM , (2007) ANDROGEN RECEPTOR COREGULATORS AND THEIR INVOLVEMENT IN THE DEVELOPMENT AND PROGRESSION OF PROSTATE CANCER.INTERNATIONAL JOURNAL OF CANCER. VOL. 120. ISSUE 4. P. 719-733 | 131 | 51% | 116 |
10 | HEEMERS, HV , TINDALL, DJ , (2007) ANDROGEN RECEPTOR (AR) COREGULATORS: A DIVERSITY OF FUNCTIONS CONVERGING ON AND REGULATING THE AR TRANSCRIPTIONAL COMPLEX.ENDOCRINE REVIEWS. VOL. 28. ISSUE 7. P. 778-808 | 136 | 39% | 288 |
Classes with closest relation at Level 1 |